LENZ Therapeutics Partners Arrotex to Launch VIZZ in ANZ
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
BOSTON, June 22, 2026 Mighty Therapeutics, formerly known as Stealth BioTherapeutics, has officially announced its corporate rebranding, marking a...
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
